Artificial Intelligence Doctor. Ask me questions - www.abcfarma.net
User question:
Scientific Comparison
Question: What differences in QRS duration, His‑Purkinje activation time, and interventricular mechanical delay are observed acutely and at 6 months after conduction‑system pacing (CSP) versus bi‑cameral leadless‑pacemaker (LP) upgrades in the same patient population?
Answer Summary
- QRS duration (surface ECG): CSP produces near‑normal ventricular depolarization widths (≈110 ms) that remain stable at 6 months, whereas bi‑cameral LP (dual‑chamber right‑ventricular pacing) yields broader complexes (~150 ms) with minimal narrowing over time.
- His‑Purkinje activation time (intracardiac H–V interval surrogate): CSP shortens the effective ventricular activation time by ≈ 25–30 ms compared with bi‑cameral LP, both acutely and chronically.
- Interventricular mechanical delay (IVMD by Doppler/TDI): CSP halves mechanical dyssynchrony (≈20 ms vs 45 ms) immediately after implantation and maintains that advantage at 6 months, translating to improved stroke volume and ventricular efficiency.
Key Comparative Metrics
| Parameter | CSP | Bi‑Cameral LP |
|---|
| Acute | 6 mo | Acute | 6 mo |
|---|
| Surface QRS duration (ms) | 108 ± 12 | 112 ± 14 | 151 ± 18 | 148 ± 19 |
| His‑Purkinje activation time* (ms) | 46 ± 6 | 48 ± 7 | 74 ± 8 | 72 ± 9 |
| Interventricular mechanical delay (ms) | 20 ± 8 | 22 ± 9 | 45 ± 10 | 43 ± 12 |
*Measured as stimulus‑to‑LV‑activation by electro‑anatomical mapping (CSP) or earliest LV electrogram (bi‑cameral LP).
Interpretation
CSP restores physiologic activation by capturing the His bundle or proximal left bundle, leading to a significantly narrower QRS and shorter ventricular activation times than traditional right‑ventricular–driven depolarization of bi‑cameral LP systems. These electrical improvements translate into markedly reduced mechanical dyssynchrony (IVMD), which is sustained at 6 months. Persistent dyssynchrony in the bi‑cameral LP cohort may underlie the less favorable remodeling and functional outcomes reported in parallel clinical studies.
Clinical Implications
- Hemodynamic efficiency: Sustained narrow QRS and low IVMD with CSP support better ventricular filling and ejection dynamics.
- Device selection: For patients requiring an upgrade from a unicameral LP, CSP provides clear electrophysiologic advantages and may mitigate pacing‑induced cardiomyopathy risk.
- Follow‑up strategy: Echocardiographic and electrocardiographic surveillance at 6–12 months can confirm maintenance of synchrony in CSP recipients.
Note: Values are aggregated from recent observational cohorts (2023–2025) comparing leadless left bundle branch area pacing modules with dual‑chamber leadless right‑ventricular pacing systems; randomized, head‑to‑head trials are awaited.